Procurement for neutralising antibodies

Id: ocds-h6vhtk-02e397
Title: Procurement for neutralising antibodies
Description: DHSC invites suppliers to provide information on neutralising antibodies and binding site, clinical trials on efficacy, safety for preventing or treating COVID-19 infection, dose&frequency, formats/routes for administering to patients, monitoring adverse affects, efficacy against SARS-CoV-2 variants, supply availability for 2021-2022 and future years and plans for regulatory approval in the UK, if not yet approved.
Buyer: Department of Health and Social Care
Date Published: Unknown
Status: Planned
Classification: 33600000: Pharmaceutical products
Value: £1 GBP
Procurement Method: ""
Procurement Method Details: Unknown
Tender Deadline: Unknown
Contract Start Date: 2025-01-23
Contract End Date: 2025-01-23
Suitable For Sme: false
Suitable For Vcse: false
Documents: No documents found.

Contract details